hero section gradient
15 handpicked stocks

Tech's Divergent Strength

While the broader market sends mixed signals, tech-focused indexes are hitting record highs, creating a clear divergence from industrial stocks. This theme focuses on the technology companies and their key suppliers that are driving this powerful, innovation-led rally.

Author avatar

Han Tan | Market Analyst

Published on July 25

Your Basket's Financial Footprint

Concise interpretation of the basket's market capitalisation and investor takeaways.

Key Takeaways for Investors:
  • Dominance by large caps generally implies greater stability, lower volatility, and closer tracking of broad market moves.
  • Use this basket as a core, long-term holding rather than a speculative, short-term growth play.
  • Expect steady, long-term appreciation potential; don't expect explosive short-term gains.
Total Market Cap
  • DELL: $100.15B

  • SMCI: $32.58B

  • NTAP: $23.77B

  • Other

About This Group of Stocks

1

Our Expert Thinking

The market is showing a clear split between technology and industrial sectors. While tech-heavy indexes hit new all-time highs, industrial benchmarks are declining. This divergence reveals investors are favoring innovation-led companies with strong future prospects, creating a powerful trend toward technology enablers.

2

What You Need to Know

This group focuses on the essential ecosystem supporting major tech companies - from semiconductor manufacturers to data infrastructure providers. These are the suppliers and service providers that form the critical backbone of the technology sector's current rally, positioned to benefit from sustained tech investment.

3

Why These Stocks

These companies were handpicked as the key enablers of the current innovation-led market leadership. They provide the hardware, software, and essential services that fuel the technology sector's momentum, offering tactical exposure to this powerful divergent trend in the market.

Why You'll Want to Watch These Stocks

🚀

Innovation Momentum Building

Tech indexes are hitting record highs while industrials decline, showing clear investor preference for innovation-led growth. This divergence creates powerful opportunities in the companies enabling this rally.

Capital Flowing to Tech Enablers

Major tech companies are investing heavily in infrastructure and innovation, directly benefiting their key suppliers and service providers. These enablers are positioned to capture significant value from this sustained momentum.

🎯

Strategic Market Positioning

While broader markets send mixed signals, these companies form the critical backbone of the technology sector's outperformance. They offer tactical exposure to one of the market's strongest trends.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Global Infrastructure Partners: UAE Exposure Risks

Global Infrastructure Partners: UAE Exposure Risks

The UAE's strategic push for economic diversification and smart city development is creating significant demand for advanced construction and infrastructure solutions. This basket provides exposure to a selection of US and EU-listed companies that supply essential materials, technology, and engineering services to the region's projects.

UAE Infrastructure Global Suppliers Breakdown

UAE Infrastructure Global Suppliers Breakdown

As the UAE continues its ambitious economic diversification, demand for world-class infrastructure creates opportunities for the companies that build it. This basket offers exposure to US and EU-listed industrial, materials, and technology firms that are integral to developing these large-scale projects.

Antiviral M&A Wave: Biotech Opportunities in 2025

Antiviral M&A Wave: Biotech Opportunities in 2025

Merck's $9.2 billion acquisition of Cidara Therapeutics strengthens its antiviral pipeline as a key patent nears expiry. This major deal signals a growing trend of pharmaceutical giants buying smaller biotechs, creating potential opportunities among companies with promising infectious disease therapies.

Frequently Asked Questions